[1] Imam K. Management and treatment of diabetes mellitus [J]. Adv Exp Med Biol, 2012, 771: 356-380. [2] Preshaw PM. Periodontal disease and diabetes[J]. J Dent, 2009, 37(8): S575-577. [3] Kim JH, Lee DE, Gunawardhana KS, et al. Effect of the interaction between periodontitis and type 1 diabetes mellitus on alveolar bone, mandibular condyle and tibia[J]. Acta Odontol Scand, 2014, 72(4): 265-273. [4] Trinchieri G, Sher A. Cooperation of Toll-like receptor signals in innate immune defence[J]. Nat Rev Immunol, 2007, 7(3): 179-190. [5] Luo W, Wang CY, Jin L. Baicalin downregulates Porphyromonas gingivalis lipopolysaccharide-upregulated IL-6 and IL-8 expression in human oral keratinocytes by negative regulation of TLR signaling [J]. PLoS One, 2012, 7(12): e51008. [6] Zeytin K, Cilolu NS, Ate F, et al. The effects of resveratrol on tendon healing of diabetic rats [J]. Acta Orthop Traumatol Turc, 2014, 48(3): 355-362. [7] Sun WL, Chen LL, Zhang SZ, et al. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis [J]. Intern Med, 2011, 50(15): 1569-1574. [8] Dasu MR, Devaraj S, Park S, et al. Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects [J]. Diabetes Care, 2010, 33(4): 861-868. [9] Takata S, Sawa Y, Uchiyama T, et al. Expression of Toll-like receptor 4 in glomerular endothelial cells under diabetic conditions [J]. Acta Histochem Cytochem, 2013, 46(1): 35-42. [10] Ma J, Chadban SJ, Zhao CY, et al. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy[J]. PLoS One, 2014, 9(5): e97985. [11] Mohammad MK, Morran M, Slotterbeck B, et al. Dysregulated Toll-like receptor expression and signaling in bone marrow-derived macrophages at the onset of diabetes in the non-obese diabetic mouse [J]. Int Immunol, 2006, 18(7): 1101-1113. [12] Ahmad R, Al-Mass A, Atizado V, et al. Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation[J]. J Inflamm (Lond), 2012, 9(1): 48. [13] Becerik S, Ozsan N, Gürkan A, et al. Toll like receptor 4 and membrane-bound CD14 expressions in gingivitis, periodontitis and CsA-induced gingival overgrowth [J]. Arch Oral Biol, 2011, 56(5): 456-465. [14] Rojo-Botello NR, García-Hernández AL, Moreno-Fierros L. Expression of toll-like receptors 2, 4 and 9 is increased in gingival tissue from patients with type 2 diabetes and chronic periodontitis [J]. J Periodontal Res, 2012, 47(1): 62-73. [15] Yang X, Zhang J, Ni J, et al. Toll-Like receptor 4 mediated hyper-responsiveness of gingival epithelial cells to LPS in high-glucose environment [J]. J Periodontol, 2014, 85(11): 1620-1628. [16] Su HC, Hung LM, Chen JK. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats [J].Am J Physiol Endocrinol Metab, 2006, 290(6): E1339-1346. [17] Jakus PB, Kalman N, Antus C, et al. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol [J]. J Nutr Biochem, 2013, 24(5): 819-823. [18] Zhang Z, Chen N, Liu JB, et al. Protective effect of resveratrol against acute lung injury induced by lipopolysaccharide via inhibiting the myd88-dependent Toll-like receptor 4 signaling pathway [J]. Mol Med Rep, 2014, 10(1): 101-106. [19] Wang Q, Li H, Xie H, et al. 25-Hydroxyvitamin D3 attenuates experimental periodontitis through downregulation of TLR4 and JAK1/STAT3 signaling in diabetic mice [J]. J Steroid Biochem Mol Biol, 2013, 135(14): 43-50. |